Skip to content

Endogenous Pain Modulation in Patients with Shoulder Arthroplasty for Osteoarthritis

Endogenous Pain Modulation in Patients with Shoulder Arthroplasty for Osteoarthritis - EPM study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53872
Enrollment
25
Registered
2022-04-15
Start date
2024-03-04
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative joint disease, Osteoarthritis

Interventions

None listed

Sponsors

Reinier Haga Orthopedisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria:  - Age >= 18 yrs  - Scheduled to undergo primary total shoulder arthroplasty (TSA) or reversed  shoulder arthroplasty (RSA) for primary shoulder osteoarthritis or cuff tear  arthropathy - American Society of Anesthesiologists score 1, 2 or 3 - Able to provide written informed consent 

Exclusion criteria

Exclusion criteria:  - Regular use of anti-depressants or anti-epileptics for any purpose, including  SNRIs and gabapentinoids - The presence of any chronic pain disorder other than osteoarthritis  - Osteoarthritis in joints other than the affected shoulder, for which  arthroplasty is/will be planned in the near future • Difficulty with or inability to perform psychophysical testing (eg. in case  of cognitive or psychiatric disorders) - Difficulty with or inability to communicate with the investigators (eg.  difficulty with the Dutch language, cognitive/memory disorders) 

Design outcomes

Primary

MeasureTime frame
The main study parameters are CPM and TS values at baseline and at 3 and 6 months after surgery, as well as the absence/presence of allodynia at baseline and at 3 and 6 months after surgery.

Secondary

MeasureTime frame
Secondary outcomes are painscores, pain catastrophizing and coping strategies at baseline and at 3 and 6 months after surgery.

Countries

Netherlands

Contacts

Public ContactB. Hesseling

Reinier Haga Orthopedisch Centrum

onderzoek@rhoc.nl079-2065595

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)